106 results
Page 2 of 6
424B5
y821ib
13 Feb 24
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.1
j6vmk6 llvjpdy
22 Jan 24
Regulation FD Disclosure
8:01am
8-K
mm1z5wmxv vo41s74l
8 Jan 24
NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors
8:21am
8-K
EX-99.2
vd84cme7wvc
8 Jan 24
NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors
8:21am
424B3
4i2 knlvsq20daf
19 Dec 23
Prospectus supplement
4:36pm
F-3
EX-1.2
582gbo1
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-23.2
hg9kbk2j9kyv 100b
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-4.2
2s3hg4pe
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-23.1
p27r6a tsji
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-5.1
hpbj1
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-4.1
e6pb6i
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
6mm122jaahrb9xpgou
7 Dec 23
Shelf registration (foreign)
4:16pm
6-K
EX-99.1
8pi4 ul6wauz
25 Sep 23
Current report (foreign)
8:10am
6-K
EX-99.1
3f0 9iqjl3
28 Aug 23
Current report (foreign)
4:16pm
424B3
1jyt9axkf2t2zdi
15 Aug 23
Prospectus supplement
4:52pm
6-K
EX-99.2
nkhfaip 2v
14 Aug 23
NewAmsterdam Pharma Announces Appointment of William “BJ” Jones, formerly of Biohaven Pharmaceuticals, as Chief Commercial Officer
4:52pm
POS AM
ystu90 wbi4cb3
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
POS AM
EX-23.4
1g2qudpxvh49k
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
POS AM
EX-23.3
yo7h4is
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
6-K
EX-99.2
m6cwfe o086
7 Aug 23
Research and development expenses
7:24am